Lucira Health Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Lucira Health.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 17.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Lucira Health reports early data for point of care chlamydia and gonorrhea assays
Sep 29Lucira COVID & Flu test gets emergency use authorization from Health Canada
Aug 11Lucira Health Sees Strong Revenue Growth But Needs More Cash
Mar 10Analysts' Revenue Estimates For Lucira Health, Inc. (NASDAQ:LHDX) Are Surging Higher
Nov 25Is Lucira Health (NASDAQ:LHDX) In A Good Position To Invest In Growth?
Jun 29Lucira Health appoints medtech veteran Kevin Collins as CRO
May 28Health Canada issues 'authorization with conditions' for Lucira's COVID-19 test kit
Apr 26In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Lucira Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2022 | 212 | -143 | -108 | -82 | N/A |
6/30/2022 | 193 | -44 | -118 | -97 | N/A |
3/31/2022 | 179 | -38 | -101 | -83 | N/A |
12/31/2021 | 93 | -65 | -116 | -101 | N/A |
9/30/2021 | 32 | -74 | -132 | -108 | N/A |
6/30/2021 | 17 | -59 | -100 | -75 | N/A |
3/31/2021 | 5 | -49 | -78 | -54 | N/A |
12/31/2020 | 0 | -37 | -51 | -33 | N/A |
9/30/2020 | N/A | -22 | -24 | -18 | N/A |
12/31/2019 | N/A | -8 | -7 | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if LHDX.Q's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if LHDX.Q's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if LHDX.Q's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if LHDX.Q's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if LHDX.Q's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LHDX.Q's Return on Equity is forecast to be high in 3 years time